Evidence map›Paper›PMID 31536603›Full record

ArticlePloS one2019

Lipopolysaccharide induces mouse translocator protein (18 kDa) expression via the AP-1 complex in the microglial cell line, BV-2.

Shuji Shimoyama, Tomonori Furukawa, Yoshiki Ogata, Yoshikazu Nikaido, Kohei Koga, Yui Sakamoto, Shinya Ueno, Kazuhiko Nakamura

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shuji ShimoyamaResearch Center for Child Mental Development, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.ORCID 0000-0001-6777-0438
Tomonori FurukawaDepartment of Neurophysiology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Yoshiki OgataDepartment of Neurophysiology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Yoshikazu NikaidoDepartment of Neurophysiology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Kohei KogaDepartment of Neurophysiology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Yui SakamotoDepartment of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Shinya UenoResearch Center for Child Mental Development, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Kazuhiko NakamuraResearch Center for Child Mental Development, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.ORCID 0000-0001-7375-5867
Hirosaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been reported that neuroinflammation occurs in the central nervous system (CNS) in patients with neuropathic pain, Alzheimer's disease and autism spectrum disorder. The 18-kDa translocator protein TSPO is used as an imaging target in positron emission tomography to detect neuroinflammation, and its expression is correlated with microglial activation. However, the mechanism underlying the transcriptional regulation of Tspo induced by inflammation is not clear. Here, we revealed that lipopolysaccharide (LPS) -induced Tspo expression was activated by the AP-1 complex in a mouse microglial cell line, BV-2. Knockdown of c-Fos and c-Jun, the components of AP-1, reduced LPS-induced Tspo expression. Furthermore, the enrichment of Sp1 in the proximal promoter region of Tspo was increased in the presence of LPS. In addition, the binding of histone deacetylase 1 (HDAC1) to the enhancer region, which contains the AP-1 site, was decreased by LPS treatment, but there were no significant differences in HDAC1 binding to the proximal promoter region with or without LPS. These results indicated that HDAC1 is involved not in the proximal promoter region but in the enhancer region. Our study revealed that inflammatory signals induce the recruitment of AP-1 to the enhancer region and Sp1 to the proximal promoter region of the Tspo gene and that Sp1 may regulate the basal expression of Tspo.

Indexed as

AnimalsBinding SitesCell LineEnhancer Elements, GeneticGene Expression RegulationHistone Deacetylase 1HumansLipopolysaccharidesMiceMicrogliaProtein BindingReceptors, GABARNA InterferenceTranscription Factor AP-1Bzrp protein, mouseHistone Deacetylase 1LipopolysaccharidesReceptors, GABATranscription Factor AP-1

Identifiers

PMID31536603
PMCPMC6752844
OpenAlexW2973986420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.